Literature DB >> 229505

Characterization of 3H-GABA receptor binding to rat brain synaptosomal membranes: effect of non GABAergic compounds.

J Hyttel.   

Abstract

Characteristics of 3H-GABA binding to rat brain synaptic membranes in vitro have been investigated. The specific binding of 3H-GABA displays saturation kinetics. Only one single population of receptor sites was found (Km = 31.3 nM) with a concentration of 2.09 pmol/mg protein. Only GABA agonists show inhibitory effect on the binding, whereas GABA antagonists, GABA-uptake inhibitors, and inhibitors of GAD and GABA-T are without effect. The order of potencies for GABA agonists are: Muscimol greater than GABA greater than or equal to 4,5-dihydromuscimol greater than 3-aminoproprane sulphonic acid greater than isoguvacine greater than THIP greater than 3-hydroxy-GABA greater than imidazol-4-acetic acid. Agonists and antagonists from other neurone systems as well as neuroleptics and benzodiazepines had no or only a very slight potency in the binding test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229505     DOI: 10.1007/bf00433051

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Muscimol binding in rat brain: association with synaptic GABA receptors.

Authors:  K Beaumont; W S Chilton; H I Yamamura; S J Enna
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

2.  Binding of [3H]alpha-dihydropicrotoxinin, a gamma-aminobutyric acid synaptic antagonist, to rat brain membranes.

Authors:  M K Ticku; M Ban; R W Olsen
Journal:  Mol Pharmacol       Date:  1978-05       Impact factor: 4.436

3.  Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system.

Authors:  M K Ticku; R W Olsen
Journal:  Life Sci       Date:  1978-05-08       Impact factor: 5.037

4.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

5.  Some factors affecting the "binding" of GABA to a membrane fraction of rat cerebral cortex.

Authors:  C Estrada
Journal:  Brain Res       Date:  1977-06-03       Impact factor: 3.252

6.  Properties of gamma-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions.

Authors:  S J Enna; S H Snyder
Journal:  Brain Res       Date:  1975-12-12       Impact factor: 3.252

7.  Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.

Authors:  B Costall; W H Funderburk; C A Leonard; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

8.  Kinetic and pharmacologic characterization of gamma-aminobutyric acid receptive sites from mammalian brain.

Authors:  B R Lester; E J Peck
Journal:  Brain Res       Date:  1979-01-26       Impact factor: 3.252

9.  Substituted benzamides as cerebral dopamine antagonists in rodents.

Authors:  P N Elliott; P Jenner; G Huizing; C D Marsden; R Miller
Journal:  Neuropharmacology       Date:  1977-05       Impact factor: 5.250

10.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

View more
  2 in total

Review 1.  Biochemical dissection of the gamma-aminobutyrate synapse.

Authors:  A J Turner; S R Whittle
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

2.  Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

Authors:  D Schmidt; W Löscher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.